Scilex Holding Co (SCLX)
0.6781
-0.06
(-8.36%)
USD |
NASDAQ |
Nov 14, 16:00
0.67
-0.01
(-1.19%)
After-Hours: 20:00
Scilex Profit Margin (Quarterly): -229.6% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -229.6% |
| March 31, 2024 | -224.0% |
| December 31, 2023 | -159.0% |
| September 30, 2023 | -351.2% |
| June 30, 2023 | -211.8% |
| Date | Value |
|---|---|
| March 31, 2023 | -290.6% |
| December 31, 2022 | -150.0% |
| September 30, 2022 | |
| June 30, 2022 | -225.1% |
| March 31, 2022 | -134.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-351.2%
Minimum
Sep 2023
-134.2%
Maximum
Mar 2022
-219.5%
Average
-224.0%
Median
Mar 2024
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 15.48% |
| Masimo Corp | 1.94% |
| Oramed Pharmaceuticals Inc | -- |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 12.32% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -117.9% |
| Gross Profit Margin (Quarterly) | 73.18% |
| Operating Margin (Quarterly) | -95.44% |
| Return on Net Operating Assets | -137.5% |